<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

Download our Perspective

KiOmed Pharma’s CCO Arnaud Loriers discusses KioMedine, the company’s novel mushroom-derived, single-injection technology for OA in an interview with SmartTRAK at the 2026 ESSKA Congress in Prague. To learn more, read our article!

KiOMed Preview